What is LOPJLB’s current signal on PBYI?

LOPJLB’s latest quantitative signal on Puma Biotechnology, Inc. (PBYI) is BUY in a BULL regime. Signals are updated daily.

What market regime is PBYI in?

Puma Biotechnology, Inc. (PBYI) is currently classified in the BULL HMM market regime on LOPJLB.

What does Puma Biotechnology, Inc. (PBYI) do?

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic H…

Where is Puma Biotechnology, Inc. based / listed?

Puma Biotechnology, Inc. is based in US, listed on NASDAQ.

Puma Biotechnology, Inc. (PBYI)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$10.29+3.21%Close

BUYBULL · day 45

[SCORES & PROFILE]

FUND: 37
VALUE: 44
GROWTH: 72
GARP: 13
TYPE: Value / Recovery

Composite of Value · Growth · GARP

ROIC12.5%

REV YoY-

ROE20.9%

EPS YoY-

ROA13.9%

GROSS

NET

[VALUATION]

P/E TTM17.72

P/E FWD53.76

SECTOR PE20.47

INDUSTRY PE13.95

P/B3.49

P/FCF-

EV/EBITDA9.48

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E3.48

ALTMAN Z-

CURR RATIO2.91

ND/EBITDA-

BETA1.23

Puma Biotechnology, Inc. (PBYI)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news